1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by ADHD Medications Revenue 1.4 Market Analysis by Type 1.4.1 Global ADHD Medications Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Stimulant 1.4.3 Non-stimulant 1.5 Market by Application 1.5.1 Global ADHD Medications Market Share by Application: 2020 VS 2026 1.5.2 Adult 1.5.3 Children 1.6 Coronavirus Disease 2019 (Covid-19): ADHD Medications Industry Impact 1.6.1 How the Covid-19 is Affecting the ADHD Medications Industry 1.6.1.1 ADHD Medications Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and ADHD Medications Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for ADHD Medications Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 ADHD Medications Market Perspective (2015-2026) 2.2 ADHD Medications Growth Trends by Regions 2.2.1 ADHD Medications Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 ADHD Medications Historic Market Share by Regions (2015-2020) 2.2.3 ADHD Medications Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 ADHD Medications Market Growth Strategy 2.3.6 Primary Interviews with Key ADHD Medications Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top ADHD Medications Players by Market Size 3.1.1 Global Top ADHD Medications Players by Revenue (2015-2020) 3.1.2 Global ADHD Medications Revenue Market Share by Players (2015-2020) 3.1.3 Global ADHD Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global ADHD Medications Market Concentration Ratio 3.2.1 Global ADHD Medications Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by ADHD Medications Revenue in 2019 3.3 ADHD Medications Key Players Head office and Area Served 3.4 Key Players ADHD Medications Product Solution and Service 3.5 Date of Enter into ADHD Medications Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global ADHD Medications Historic Market Size by Type (2015-2020) 4.2 Global ADHD Medications Forecasted Market Size by Type (2021-2026) 5 ADHD Medications Breakdown Data by Application (2015-2026) 5.1 Global ADHD Medications Market Size by Application (2015-2020) 5.2 Global ADHD Medications Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America ADHD Medications Market Size (2015-2020) 6.2 ADHD Medications Key Players in North America (2019-2020) 6.3 North America ADHD Medications Market Size by Type (2015-2020) 6.4 North America ADHD Medications Market Size by Application (2015-2020) 7 Europe 7.1 Europe ADHD Medications Market Size (2015-2020) 7.2 ADHD Medications Key Players in Europe (2019-2020) 7.3 Europe ADHD Medications Market Size by Type (2015-2020) 7.4 Europe ADHD Medications Market Size by Application (2015-2020) 8 China 8.1 China ADHD Medications Market Size (2015-2020) 8.2 ADHD Medications Key Players in China (2019-2020) 8.3 China ADHD Medications Market Size by Type (2015-2020) 8.4 China ADHD Medications Market Size by Application (2015-2020) 9 Japan 9.1 Japan ADHD Medications Market Size (2015-2020) 9.2 ADHD Medications Key Players in Japan (2019-2020) 9.3 Japan ADHD Medications Market Size by Type (2015-2020) 9.4 Japan ADHD Medications Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia ADHD Medications Market Size (2015-2020) 10.2 ADHD Medications Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia ADHD Medications Market Size by Type (2015-2020) 10.4 Southeast Asia ADHD Medications Market Size by Application (2015-2020) 11 India 11.1 India ADHD Medications Market Size (2015-2020) 11.2 ADHD Medications Key Players in India (2019-2020) 11.3 India ADHD Medications Market Size by Type (2015-2020) 11.4 India ADHD Medications Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America ADHD Medications Market Size (2015-2020) 12.2 ADHD Medications Key Players in Central & South America (2019-2020) 12.3 Central & South America ADHD Medications Market Size by Type (2015-2020) 12.4 Central & South America ADHD Medications Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Amneal Pharmaceuticals 13.1.1 Amneal Pharmaceuticals Company Details 13.1.2 Amneal Pharmaceuticals Business Overview and Its Total Revenue 13.1.3 Amneal Pharmaceuticals ADHD Medications Introduction 13.1.4 Amneal Pharmaceuticals Revenue in ADHD Medications Business (2015-2020)) 13.1.5 Amneal Pharmaceuticals Recent Development 13.2 Eli Lilly and Co. 13.2.1 Eli Lilly and Co. Company Details 13.2.2 Eli Lilly and Co. Business Overview and Its Total Revenue 13.2.3 Eli Lilly and Co. ADHD Medications Introduction 13.2.4 Eli Lilly and Co. Revenue in ADHD Medications Business (2015-2020) 13.2.5 Eli Lilly and Co. Recent Development 13.3 Johnson and Johnson Services 13.3.1 Johnson and Johnson Services Company Details 13.3.2 Johnson and Johnson Services Business Overview and Its Total Revenue 13.3.3 Johnson and Johnson Services ADHD Medications Introduction 13.3.4 Johnson and Johnson Services Revenue in ADHD Medications Business (2015-2020) 13.3.5 Johnson and Johnson Services Recent Development 13.4 NEOS Therapeutic 13.4.1 NEOS Therapeutic Company Details 13.4.2 NEOS Therapeutic Business Overview and Its Total Revenue 13.4.3 NEOS Therapeutic ADHD Medications Introduction 13.4.4 NEOS Therapeutic Revenue in ADHD Medications Business (2015-2020) 13.4.5 NEOS Therapeutic Recent Development 13.5 Takeda Pharmaceutical 13.5.1 Takeda Pharmaceutical Company Details 13.5.2 Takeda Pharmaceutical Business Overview and Its Total Revenue 13.5.3 Takeda Pharmaceutical ADHD Medications Introduction 13.5.4 Takeda Pharmaceutical Revenue in ADHD Medications Business (2015-2020) 13.5.5 Takeda Pharmaceutical Recent Development 13.6 Pfizer 13.6.1 Pfizer Company Details 13.6.2 Pfizer Business Overview and Its Total Revenue 13.6.3 Pfizer ADHD Medications Introduction 13.6.4 Pfizer Revenue in ADHD Medications Business (2015-2020) 13.6.5 Pfizer Recent Development 13.7 Lupin 13.7.1 Lupin Company Details 13.7.2 Lupin Business Overview and Its Total Revenue 13.7.3 Lupin ADHD Medications Introduction 13.7.4 Lupin Revenue in ADHD Medications Business (2015-2020) 13.7.5 Lupin Recent Development 13.8 Shire 13.8.1 Shire Company Details 13.8.2 Shire Business Overview and Its Total Revenue 13.8.3 Shire ADHD Medications Introduction 13.8.4 Shire Revenue in ADHD Medications Business (2015-2020) 13.8.5 Shire Recent Development 13.9 Mallinckrodt 13.9.1 Mallinckrodt Company Details 13.9.2 Mallinckrodt Business Overview and Its Total Revenue 13.9.3 Mallinckrodt ADHD Medications Introduction 13.9.4 Mallinckrodt Revenue in ADHD Medications Business (2015-2020) 13.9.5 Mallinckrodt Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. ADHD Medications Key Market Segments Table 2. Key Players Covered: Ranking by ADHD Medications Revenue Table 3. Ranking of Global Top ADHD Medications Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global ADHD Medications Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Stimulant Table 6. Key Players of Non-stimulant Table 7. COVID-19 Impact Global Market: (Four ADHD Medications Market Size Forecast Scenarios) Table 8. Opportunities and Trends for ADHD Medications Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for ADHD Medications Players to Combat Covid-19 Impact Table 12. Global ADHD Medications Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global ADHD Medications Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global ADHD Medications Market Size by Regions (2015-2020) (US$ Million) Table 15. Global ADHD Medications Market Share by Regions (2015-2020) Table 16. Global ADHD Medications Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global ADHD Medications Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. ADHD Medications Market Growth Strategy Table 22. Main Points Interviewed from Key ADHD Medications Players Table 23. Global ADHD Medications Revenue by Players (2015-2020) (Million US$) Table 24. Global ADHD Medications Market Share by Players (2015-2020) Table 25. Global Top ADHD Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ADHD Medications as of 2019) Table 26. Global ADHD Medications by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players ADHD Medications Product Solution and Service Table 29. Date of Enter into ADHD Medications Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global ADHD Medications Market Size by Type (2015-2020) (Million US$) Table 32. Global ADHD Medications Market Size Share by Type (2015-2020) Table 33. Global ADHD Medications Revenue Market Share by Type (2021-2026) Table 34. Global ADHD Medications Market Size Share by Application (2015-2020) Table 35. Global ADHD Medications Market Size by Application (2015-2020) (Million US$) Table 36. Global ADHD Medications Market Size Share by Application (2021-2026) Table 37. North America Key Players ADHD Medications Revenue (2019-2020) (Million US$) Table 38. North America Key Players ADHD Medications Market Share (2019-2020) Table 39. North America ADHD Medications Market Size by Type (2015-2020) (Million US$) Table 40. North America ADHD Medications Market Share by Type (2015-2020) Table 41. North America ADHD Medications Market Size by Application (2015-2020) (Million US$) Table 42. North America ADHD Medications Market Share by Application (2015-2020) Table 43. Europe Key Players ADHD Medications Revenue (2019-2020) (Million US$) Table 44. Europe Key Players ADHD Medications Market Share (2019-2020) Table 45. Europe ADHD Medications Market Size by Type (2015-2020) (Million US$) Table 46. Europe ADHD Medications Market Share by Type (2015-2020) Table 47. Europe ADHD Medications Market Size by Application (2015-2020) (Million US$) Table 48. Europe ADHD Medications Market Share by Application (2015-2020) Table 49. China Key Players ADHD Medications Revenue (2019-2020) (Million US$) Table 50. China Key Players ADHD Medications Market Share (2019-2020) Table 51. China ADHD Medications Market Size by Type (2015-2020) (Million US$) Table 52. China ADHD Medications Market Share by Type (2015-2020) Table 53. China ADHD Medications Market Size by Application (2015-2020) (Million US$) Table 54. China ADHD Medications Market Share by Application (2015-2020) Table 55. Japan Key Players ADHD Medications Revenue (2019-2020) (Million US$) Table 56. Japan Key Players ADHD Medications Market Share (2019-2020) Table 57. Japan ADHD Medications Market Size by Type (2015-2020) (Million US$) Table 58. Japan ADHD Medications Market Share by Type (2015-2020) Table 59. Japan ADHD Medications Market Size by Application (2015-2020) (Million US$) Table 60. Japan ADHD Medications Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players ADHD Medications Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players ADHD Medications Market Share (2019-2020) Table 63. Southeast Asia ADHD Medications Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia ADHD Medications Market Share by Type (2015-2020) Table 65. Southeast Asia ADHD Medications Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia ADHD Medications Market Share by Application (2015-2020) Table 67. India Key Players ADHD Medications Revenue (2019-2020) (Million US$) Table 68. India Key Players ADHD Medications Market Share (2019-2020) Table 69. India ADHD Medications Market Size by Type (2015-2020) (Million US$) Table 70. India ADHD Medications Market Share by Type (2015-2020) Table 71. India ADHD Medications Market Size by Application (2015-2020) (Million US$) Table 72. India ADHD Medications Market Share by Application (2015-2020) Table 73. Central & South America Key Players ADHD Medications Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players ADHD Medications Market Share (2019-2020) Table 75. Central & South America ADHD Medications Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America ADHD Medications Market Share by Type (2015-2020) Table 77. Central & South America ADHD Medications Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America ADHD Medications Market Share by Application (2015-2020) Table 79. Amneal Pharmaceuticals Company Details Table 80. Amneal Pharmaceuticals Business Overview Table 81. Amneal Pharmaceuticals Product Table 82. Amneal Pharmaceuticals Revenue in ADHD Medications Business (2015-2020) (Million US$) Table 83. Amneal Pharmaceuticals Recent Development Table 84. Eli Lilly and Co. Company Details Table 85. Eli Lilly and Co. Business Overview Table 86. Eli Lilly and Co. Product Table 87. Eli Lilly and Co. Revenue in ADHD Medications Business (2015-2020) (Million US$) Table 88. Eli Lilly and Co. Recent Development Table 89. Johnson and Johnson Services Company Details Table 90. Johnson and Johnson Services Business Overview Table 91. Johnson and Johnson Services Product Table 92. Johnson and Johnson Services Revenue in ADHD Medications Business (2015-2020) (Million US$) Table 93. Johnson and Johnson Services Recent Development Table 94. NEOS Therapeutic Company Details Table 95. NEOS Therapeutic Business Overview Table 96. NEOS Therapeutic Product Table 97. NEOS Therapeutic Revenue in ADHD Medications Business (2015-2020) (Million US$) Table 98. NEOS Therapeutic Recent Development Table 99. Takeda Pharmaceutical Company Details Table 100. Takeda Pharmaceutical Business Overview Table 101. Takeda Pharmaceutical Product Table 102. Takeda Pharmaceutical Revenue in ADHD Medications Business (2015-2020) (Million US$) Table 103. Takeda Pharmaceutical Recent Development Table 104. Pfizer Company Details Table 105. Pfizer Business Overview Table 106. Pfizer Product Table 107. Pfizer Revenue in ADHD Medications Business (2015-2020) (Million US$) Table 108. Pfizer Recent Development Table 109. Lupin Company Details Table 110. Lupin Business Overview Table 111. Lupin Product Table 112. Lupin Revenue in ADHD Medications Business (2015-2020) (Million US$) Table 113. Lupin Recent Development Table 114. Shire Business Overview Table 115. Shire Product Table 116. Shire Company Details Table 117. Shire Revenue in ADHD Medications Business (2015-2020) (Million US$) Table 118. Shire Recent Development Table 119. Mallinckrodt Company Details Table 120. Mallinckrodt Business Overview Table 121. Mallinckrodt Product Table 122. Mallinckrodt Revenue in ADHD Medications Business (2015-2020) (Million US$) Table 123. Mallinckrodt Recent Development Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Global ADHD Medications Market Share by Type: 2020 VS 2026 Figure 2. Stimulant Features Figure 3. Non-stimulant Features Figure 4. Global ADHD Medications Market Share by Application: 2020 VS 2026 Figure 5. Adult Case Studies Figure 6. Children Case Studies Figure 7. ADHD Medications Report Years Considered Figure 8. Global ADHD Medications Market Size YoY Growth 2015-2026 (US$ Million) Figure 9. Global ADHD Medications Market Share by Regions: 2020 VS 2026 Figure 10. Global ADHD Medications Market Share by Regions (2021-2026) Figure 11. Porter's Five Forces Analysis Figure 12. Global ADHD Medications Market Share by Players in 2019 Figure 13. Global Top ADHD Medications Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ADHD Medications as of 2019 Figure 14. The Top 10 and 5 Players Market Share by ADHD Medications Revenue in 2019 Figure 15. North America ADHD Medications Market Size YoY Growth (2015-2020) (Million US$) Figure 16. Europe ADHD Medications Market Size YoY Growth (2015-2020) (Million US$) Figure 17. China ADHD Medications Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Japan ADHD Medications Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Southeast Asia ADHD Medications Market Size YoY Growth (2015-2020) (Million US$) Figure 20. India ADHD Medications Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Central & South America ADHD Medications Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. Amneal Pharmaceuticals Revenue Growth Rate in ADHD Medications Business (2015-2020) Figure 24. Eli Lilly and Co. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Eli Lilly and Co. Revenue Growth Rate in ADHD Medications Business (2015-2020) Figure 26. Johnson and Johnson Services Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Johnson and Johnson Services Revenue Growth Rate in ADHD Medications Business (2015-2020) Figure 28. NEOS Therapeutic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. NEOS Therapeutic Revenue Growth Rate in ADHD Medications Business (2015-2020) Figure 30. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Takeda Pharmaceutical Revenue Growth Rate in ADHD Medications Business (2015-2020) Figure 32. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Pfizer Revenue Growth Rate in ADHD Medications Business (2015-2020) Figure 34. Lupin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Lupin Revenue Growth Rate in ADHD Medications Business (2015-2020) Figure 36. Shire Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Shire Revenue Growth Rate in ADHD Medications Business (2015-2020) Figure 38. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Mallinckrodt Revenue Growth Rate in ADHD Medications Business (2015-2020) Figure 40. Bottom-up and Top-down Approaches for This Report Figure 41. Data Triangulation Figure 42. Key Executives Interviewed

Amneal Pharmaceuticals Eli Lilly and Co. Johnson and Johnson Services NEOS Therapeutic Takeda Pharmaceutical Pfizer Lupin Shire Mallinckrodt